Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts John Davis brings direct clinical expertise as...
Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer Key appointment bringing 30 years of drug discovery and development expertise as the Company continues to build a...
Event brings together leading academics, industry representatives and investors to share progress and discuss future directions in dark genome researchMeeting aims to achieve a better understanding of...
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board Dr Greig brings more than 40 years of experience in the biopharmaceutical sectorExperienced Chair who has led...